No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents* / adverse effects
-
Antineoplastic Agents* / pharmacokinetics
-
Antineoplastic Agents* / therapeutic use
-
Clinical Trials as Topic
-
Humans
-
Microtubules / metabolism*
-
Molecular Structure
-
Neoplasms / drug therapy*
-
Neoplasms / metabolism
-
Oligopeptides / adverse effects
-
Oligopeptides / pharmacokinetics
-
Oligopeptides / therapeutic use
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Oligopeptides
-
tasidotin